Maxis Clinical Sciences wishes you a Happy Fourth of July! It's a day filled with tradition, but let's not forget the significance — a celebration of America's independence! Here's to honoring the past and building a brighter future. #4thOfJuly #FourthofJuly #USIndependenceDay #MaxisClinicalSciences
Maxis Clinical Sciences’ Post
More Relevant Posts
-
Did you know? AAPI individuals have excelled in science, technology, medicine, and the arts! This May, let's celebrate their achievements and inspire future generations. #AAPIMonth #TalentManagement #AAPHeritageMonth #RangCares #IMatterAlly #RangTechnologies #RangHealthcare #RangLifesciences
To view or add a comment, sign in
-
-
Prepping for one of the most exciting weeks of the year, ACSM’s 2024 Annual Meeting! This is my FIRST annual meeting, partly because it’s in #Boston this year. I’m so excited to finally attend one of these prestigious conferences!!! Lots of exciting lectures, symposiums, and poster presentations on the schedule. Let’s go! 💪🏼 #ACSM #ACSM2024 #ACSMCEP #ACSMCEPA #exercisephysiology #exercisephysiologist #clinicalexercisephysiology #clinicalexercisephysiologist #conference
To view or add a comment, sign in
-
-
Are you attending OCT New England this week? Make sure to stop by Booth #61 to speak about how offering virtual care in your trial can: - accelerate recruitment - increase retention - increase diversity ⬇️ Meaning faster delivery to market and quicker access to treatment for patients. #OCTNewEngland #clinicaltrials #virtualsite #decentralizedtrials #Metasite #clinicalresearch
Join us at the 15th annual OCT New England event in Boston next week (Booth #61). Eleanor "Desi" Young and Andrew Trotta will be on site to share how Science 37 supports clinical trial sponsors through a virtual site—delivering expansive access and accelerated recruitment. This is a great opportunity to learn more about the Metasite™ and ask any questions you have about this important model of research. See you there! https://lnkd.in/eCN6ws95 #OCTNewEngland #OCT #clinicalresearch #clinicaltrials #decentralizedtrials
To view or add a comment, sign in
-
-
There’s more to #mould or #mold in #WaterDamageBuildings such as #endotoxins & #Actinomycetes .
Save the Date - CIRSx events are kicking off in 2024: January 12 we are hosting a webinar with six esteemed industry experts. Register now for "I Dream of Genie" with Dr. Ritchie Shoemaker, Dr. James Ryan, Louise Carder, MSc, Peg DiTulio, FNP, Larry Schwartz, and Dr. Scott McMahon. Secure your spot today on our website (www.cirsx.com/idog6-1). May 16-19 we will convene in Frisco, Texas for the CIRSx Annual Conference - you can sign up now to receive updates as the roll in. #CIRSx #CIRS #events #savethedate #research #medicaldoctors #conference
To view or add a comment, sign in
-
-
Today, we at Basilea reported strong #2023results with a profitability significantly above guidance, whilst substantially expanding our R&D #portfolio. 🌎 Our focus is on #infectiousdiseases, an area with a high medical need worldwide. We develop and bring to market new #antifungals and #antibacterials to help people with severe, life-threatening infections. 💬 Basilea CEO David Veitch states: “With three #clinical and one preclinical stage compounds added to our portfolio in 2023 and a further preclinical program early in 2024, we have laid the foundation for future growth and are establishing Basilea as the leading anti-infectives company - to serve #patients around the world." 📽 Watch the full-year 2023 update with David Veitch 👇 Complete Basilea Full Year Report 2023: https://lnkd.in/ebE3d2h https://lnkd.in/eS2eepuE #basileapharma #basileapharmaceutica
Full-year 2023 Update David Veitch
https://vimeo.com/
To view or add a comment, sign in
-
ALPSlimb is dedicated to bringing clinicians together and promoting collaboration and team-based care. This approach not only helps prevent limb loss but also leads to better outcomes and quality of life for patients. ALPS' founding Scientific Chair, Dr. Michael Conte, had this to say about the importance of teamwork: “We founded ALPS out of a desire to better promote education, awareness, and science around what it takes to save limbs[...] and a dire need to extend and collaborate and learn from each other." If you'd like to connect with Dr. Conte and other clinicians who are equally as passionate about limb preservation, consider signing up for an ALPS membership! Click here to register: https://lnkd.in/eXnRMX6 We value our members and help them meet their professional goals in several ways, including: - The opportunity to apply for our ALPS Traveling Fellowship, which provides recipients up to $7,500 and the chance to visit two limb preservation centers of excellence; - Access to ALPS’ international job board; - Keeping up to date with what is happening in limb preservation; - Eligibility to participate in our newly created ALPS education committee, responsible for patient and professional education, such as publications, webinars, e-learning and other educational material; and - Discounts on registration fees for this year's DFCon. Become a member, find “Sole-mates” and build your limb preservation team today! #ALPS #LimbPreservation #ActAgainstAmputation #LimbLoss #Teamwork #LimbSalvage #ToeFlowandGo David Armstrong, Georgia Krehbiel, Ryan Crews, Stephanie Wu, DPM, MSc, Joseph Mills MD, Brian D. Lepow, Michael Conte, Annkathrin Mathe, Alison Evans
Dr. Michael Conte on Why ALPS Was Founded
To view or add a comment, sign in
-
Simulation is an important tool to support innovation healthcare. Our researchers are carving new paths in this field thanks to the support of funders such as AMS Healthcare.
We’ve had a baby at Mohawk College! Meet baby Sunita, she is a high-fidelity ultrasound simulation manikin that will provide our students the first-ever chance to practice paediatric scanning in a risk-free environment! Thank you to the generous support of the Mohawk College Foundation, our fearless leaders Laura Thomas Jennifer Burton , trailblazing researchers Babitha Thampinathan with incredible support from IDEAWORKS at Mohawk College , the DCS faculty and students Stella Crawford Calvin Meerveld and DCS research students! Full video at: https://lnkd.in/dUVZ6f_R
To view or add a comment, sign in
-
🌍✨Today, May 20th, we celebrate International Clinical Trials Day, marking the anniversary of the first clinical trial by Scottish physician James Lind aboard the HMS Salisbury in 1747. Lind's pioneering work laid the foundation for modern clinical research.✨🌍 🍋 In the 18th century, scurvy was a deadly threat to sailors, caused by a lack of vitamin C. It devastated entire fleets and claimed more lives at sea than all other diseases, shipwrecks, or battles combined. ⚓ James Lind, a surgeon on the HMS Salisbury, was determined to find a cure. He selected 12 sailors with scurvy, divided them into pairs, and tested six treatments, including citrus fruits. The men who received citrus showed significant improvement within a week. 💡 Lind’s work illustrates the importance of experimentation in medical science, paving the way for today's controlled clinical trials. 🎆 💊 As we celebrate International Clinical Trials Day, we honor James Lind and all researchers dedicated to advancing medical science. Their work saves lives and improves the quality of life worldwide. 👨🏽⚕️ 👩🏽⚕️ At DocNexus we are proud to play a small role in helping connect scientists to usher in the next-generation of life-saving medicines and clinical research! #InternationalClinicalTrialsDay #HealthcareHeroes #MedicalInnovation #JamesLind #FightAgainstScurvy
To view or add a comment, sign in
-
-
🎥 #SCAI2024 Program Chair J. Dawn Abbott, MD, FSCAI, highlights the top moments from this year’s conference, while #SCAI2025 Program Chair Binita Shah, MD, FSCAI, shares exciting reasons to attend next year! Watch the interview and share your favorite moments from this year and your hopes for 2025 in the comments below! ➡️ https://lnkd.in/guSXGhSt #InterventionalCardiology
SCAI 2024 Highlights from Program Chairs Dr. J. Dawn Abbott and Dr. Binita Shah
https://www.youtube.com/
To view or add a comment, sign in
More from this author
-
FDA Announces Draft Guidance on RWD in Pharmacoepidemiological Studies
Maxis Clinical Sciences 2w -
Diversity Action Plans Now Required by FDA for Sponsors of Certain Clinical Trials
Maxis Clinical Sciences 1mo -
Bringing New Treatments to Patients Faster with Regulatory-Grade Synthetic Control Arms
Maxis Clinical Sciences 1mo